ARR

Armour Residential REIT (ARR) December 2024 Update

Armour Residential REIT, Inc. (NYSE: ARR) has released its monthly update for December 2024, revealing key data as of November 30, 2024. Let's take a closer look at some of the important metrics.

The common stock price stands at $18.92, while the debt-equity ratio is 7.9, and the implied leverage is 7.7. The total liquidity is reported at $654.2 million.

In terms of dividends, the common dividend for December 2024 is $0.24, with the common ex-dividend date/record date set at 12/16/2024 and the pay date on 12/30/2024.

The portfolio breakdown as of November 30, 2024, shows that agency CMBS accounts for 4.2% of the portfolio with a current value of $514.3 million. The effective duration using current values for this segment is 4.2. Additionally, the agency portfolio represents 100% of the total portfolio, with a value of $12,313 million.

Moving on to the repurchase (repo) positions, Buckler Securities LLC has provided $5,141 million, representing 45.3% of the repo positions with Armour. The weighted average original term for these positions is 35 days, with a weighted average remaining term of 18 days.

Furthermore, Armour's interest rate swaps show a total notional amount of $6,932 million, with a weighted average remaining term of 75 months and a weighted average rate of 1.56%.

These figures provide a snapshot of Armour Residential REIT, Inc.'s financial standing and investment strategies as of the end of November 2024. As a result of these announcements, the company's shares have moved -0.4% on the market, and are now trading at a price of $19.38. For the full picture, make sure to review ARMOUR Residential REIT's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS